Market revenue in 2023 | USD 577.7 million |
Market revenue in 2030 | USD 1,170.7 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Polymerase chain reaction (pcr) tests |
Fastest growing segment | Polymerase Chain Reaction (PCR) tests |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polymerase Chain Reaction (PCR) tests |
Key market players worldwide | Roche, Becton Dickinson & Co, Danaher Corp, Abbott Laboratories, Illumina Inc, Siemens Healthineers AG ADR, BioMerieux SA, Novartis AG ADR, Bio-Rad Laboratories Inc, Seegene |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleic acid amplification testing market will help companies and investors design strategic landscapes.
Polymerase chain reaction (pcr) tests was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Middle East & Africa nucleic acid amplification testing market based on polymerase chain reaction (pcr) tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa nucleic acid amplification testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa nucleic acid amplification testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account